You are here

Our science / Clinical Trials / Find a Trial / NCT00159679

Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

Back to Search Print Save as PDF Bookmark Trial

NCT00159679

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hot Springs, Arkansas, 71913 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Painful Diabetic Neuropathy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adults with Type 1 or 2 diabetes

- Patients must have pain in their lower legs or feet due to painful diabetic neuropathy
that has lasted for at least 3 months

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients must not be in poor or unstable health.

NCT00159679
Pfizer
Completed
Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Painful Diabetic Neuropathy
Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
NCT01050218
All Genders
Painful Diabetic Neuropathy
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
NCT01057693
All Genders
18+
Years
Multiple Sites
Painful Diabetic Neuropathy
To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
NCT00150423
All Genders
Painful Diabetic Neuropathy
Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.
NCT00141401
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now